Boston Scientific said Monday it has invested $1.5 billion to acquire a 34% equity stake in MiRus, a company developing a balloon-expandable transcatheter aortic valve replacement system. The agreement gives Boston Scientific an exclusive option to acquire the MiRus TAVR system, subject to additional payments and the completion of certain clinical and regulatory milestones. Boston Scientific said it may opt to acquire the rest of the TAVR business for additional cash payments totaling $3 billion.
Read the full article: Boston Scientific Buys $1.5B Stake in TAVR Developer MiRus //
Source: https://www.medtechdive.com/news/boston-scientific-buys-15b-stake-in-tavr-developer-mirus/820492/